Provided by Tiger Fintech (Singapore) Pte. Ltd.

TherapeuticsMD

1.12
-0.0500-4.27%
Post-market: 1.170.0500+4.46%19:09 EDT
Volume:27.87K
Turnover:31.60K
Market Cap:12.96M
PE:-6.00
High:1.19
Open:1.18
Low:1.11
Close:1.17
Loading ...

TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Yesterday

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
24 Jun

TherapeuticsMD Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
19 Jun

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
18 Jun

TherapeuticsMD Inc. Stock Slides 7.7%, Underperforms Market

Dow Jones
·
17 Jun

TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
14 Jun

TherapeuticsMD Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
11 Jun

TherapeuticsMD Inc. Stock Rises 12.6%, Outperforms Market

Dow Jones
·
07 Jun

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
05 Jun

TherapeuticsMD Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
04 Jun

TherapeuticsMD Inc. Stock Slips 24.7%, Underperforms Market

Dow Jones
·
03 Jun

Mayne Pharma Group Unit Seeks Over $11.5 Million in Damages in US Court Complaint Against TherapeuticsMD

MT Newswires Live
·
02 Jun

TherapeuticsMD Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
29 May

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
28 May

Mayne Pharma slumps 30% as Cosette threatens to scrap $432 million deal

Reuters
·
21 May

TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
20 May

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
17 May

TherapeuticsMD Inc. Stock Slides 3.9%, Underperforms Market

Dow Jones
·
15 May

TherapeuticsMD Q1 EPS $(0.06) Up From $(0.07) YoY, Sales $393.00K Up From $313.00K YoY

Benzinga
·
14 May

BRIEF-TherapeuticsMD Q1 Operating Expenses USD 1.264 Million

Reuters
·
14 May